Faron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Above 50-Day Moving Average of $124.14

Faron Pharmaceuticals Oy (LON:FARN)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 124.14 ($1.60) and traded as high as GBX 169 ($2.17). Faron Pharmaceuticals Oy shares last traded at GBX 162.50 ($2.09), with a volume of 8,534 shares trading hands.

Faron Pharmaceuticals Oy Stock Performance

The company has a market capitalization of £117.02 million, a P/E ratio of -396.34 and a beta of -0.13. The stock’s 50 day moving average is GBX 123.58 and its 200-day moving average is GBX 164.74. The company has a debt-to-equity ratio of 121.51, a current ratio of 0.59 and a quick ratio of 1.09.

Faron Pharmaceuticals Oy Company Profile

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.